Continuous Ambulatory Cardiac Monitoring for Recurrent Atrial Fibrillation After Sepsis

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 125 participants.

Also called NCT05217485

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 125 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05217485
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05217485. Allocation not applicable; no masking; primary purpose diagnostic. Start 2022-03 (anticipated); primary completion 2023-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Continuous Ambulatory Cardiac Monitoring for Recurrent Atrial Fibrillation After Sepsis
Acronym
CAMS-AF
Condition
Sepsis
Condition
Infections
Condition
Cardiac Arrhythmia
Intervention (Device)
Zio 14-day cardiac patch
Lead sponsor
Cambridge University Hospitals NHS Foundation Trust (class: other)
Collaborator
University of Cambridge (class: other)

Record details

Record id
cardio:ct-nct05217485
Content hash
4623334d757a65d91585489a7e8405569114fd6856f8edd78f26f6ee360ffb89